# Nuclide record primary-aldosteronism (indication). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/indications/primary-aldosteronism/>
  a schema:MedicalCondition ;
  nuclide:kind "indication" ;
  schema:identifier "primary-aldosteronism" ;
  schema:name "Primary aldosteronism"@en ;
  schema:alternateName "PA"@en, "primary hyperaldosteronism"@en, "hyperaldosteronism"@en ;
  schema:description "Primary aldosteronism is a hormonal condition in which one or both adrenal glands make too much of a hormone that raises blood pressure. It is a common but badly under-diagnosed cause of hypertension, usually flagged by a blood test, and curable with surgery when only one gland is overactive."@en ;
  schema:url <https://nuclide.cc/indications/primary-aldosteronism/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://academic.oup.com/jcem/article/110/9/2453/8196671>, <https://www.endocrine.org/clinical-practice-guidelines/primary-aldosteronism-2>, <https://www.endocrine.org/news-and-advocacy/news-room/2025/endocrine-society-guideline-calls-for-increased-screening-for-common-cause-of-high-blood-pressure>, <https://med.stanford.edu/content/dam/sm/urology/JJimages/publications/Screening-rates-for-primary-aldosteronism-in-resistant-hypertension-A-cohort-study.pdf>, <https://www.ccjm.org/content/93/9/515>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC12459304/> ;
  nuclide:tag "endocrine", "hypertension", "screening" ;
  nuclide:related <https://nuclide.cc/targets/cxcr4/>, <https://nuclide.cc/drugs/ga-68-pentixafor/>, <https://nuclide.cc/opportunities/opp-cxcr4-primary-aldosteronism/>, <https://nuclide.cc/isotopes/ga-68/>, <https://nuclide.cc/isotopes/c-11/> ;
  nuclide:pipeline <https://nuclide.cc/opportunities/opp-cxcr4-primary-aldosteronism/>, <https://nuclide.cc/targets/cxcr4/>, <https://nuclide.cc/drugs/ga-68-pentixafor/>, <https://nuclide.cc/technologies/pet-ct/> .